358 related articles for article (PubMed ID: 9291288)
1. The in vitro and in vivo effect of corticosteroids on basophil releasability in patients with mild and severe bronchial asthma.
Kivity S; Onn A; Agami O; Fireman E
Clin Exp Allergy; 1997 Aug; 27(8):909-14. PubMed ID: 9291288
[TBL] [Abstract][Full Text] [Related]
2. Regulation of human basophil mediator release by cytokines. I. Interaction with antiinflammatory steroids.
Schleimer RP; Derse CP; Friedman B; Gillis S; Plaut M; Lichtenstein LM; MacGlashan DW
J Immunol; 1989 Aug; 143(4):1310-7. PubMed ID: 2473127
[TBL] [Abstract][Full Text] [Related]
3. Effect of montelukast on basophil releasability in patients with asthma.
Sade K; Kivity S; Fireman E; Schwartz Y; Kivity S
Isr Med Assoc J; 2005 Dec; 7(12):792-5. PubMed ID: 16382702
[TBL] [Abstract][Full Text] [Related]
4. In vivo characterization of the anti-inflammatory effect of cyclosporin A on human basophils.
Casolaro V; Spadaro G; Patella V; Marone G
J Immunol; 1993 Nov; 151(10):5563-73. PubMed ID: 7693814
[TBL] [Abstract][Full Text] [Related]
5. Activated status of basophils in chronic urticaria leads to interleukin-3 hyper-responsiveness and enhancement of histamine release induced by anti-IgE stimulus.
Lourenço FD; Azor MH; Santos JC; Prearo E; Maruta CW; Rivitti EA; Duarte AJ; Sato MN
Br J Dermatol; 2008 May; 158(5):979-86. PubMed ID: 18341658
[TBL] [Abstract][Full Text] [Related]
6. Reduced priming effect of interleukin 3 on IgE mediated basophil histamine release in patients with systemic sclerosis.
Tedeschi A; Salmaso C; Milazzo N; Miadonna A
J Rheumatol; 1998 Jul; 25(7):1320-4. PubMed ID: 9676763
[TBL] [Abstract][Full Text] [Related]
7. Importance of interleukin-3 on histamine release from human basophils.
Sugiyama H; Eda R; Hopp RJ; Bewtra AK; Townley RG
Ann Allergy; 1993 Oct; 71(4):391-5. PubMed ID: 7692771
[TBL] [Abstract][Full Text] [Related]
8. Human basophil releasability. III. Genetic control of human basophil releasability.
Marone G; Poto S; Celestino D; Bonini S
J Immunol; 1986 Dec; 137(11):3588-92. PubMed ID: 2431036
[TBL] [Abstract][Full Text] [Related]
9. Basophil histamine release decreases during omalizumab therapy in allergic asthmatics.
Noga O; Hanf G; Kunkel G; Kleine-Tebbe J
Int Arch Allergy Immunol; 2008; 146(1):66-70. PubMed ID: 18087163
[TBL] [Abstract][Full Text] [Related]
10. Basophil histamine release and leukotriene production in response to anti-IgE and anti-IgE receptor antibodies. Comparison of normal subjects and patients with urticaria, atopic dermatitis or bronchial asthma.
Bischoff SC; Zwahlen R; Stucki M; Müllner G; de Weck AL; Stadler BM; Dahinden CA
Int Arch Allergy Immunol; 1996 Jul; 110(3):261-71. PubMed ID: 8688673
[TBL] [Abstract][Full Text] [Related]
11. Autologous serum skin test reactivity in patients with non-allergic asthma.
Tedeschi A; Comi AL; Lorini M; Tosini C; Miadonna A
Clin Exp Allergy; 2005 Jul; 35(7):849-53. PubMed ID: 16008669
[TBL] [Abstract][Full Text] [Related]
12. Enhanced IgE-dependent basophil histamine release and airway reactivity in asthma.
Gaddy JN; Busse WW
Am Rev Respir Dis; 1986 Nov; 134(5):969-74. PubMed ID: 3096179
[TBL] [Abstract][Full Text] [Related]
13. IL-3-induced histamine release from human basophils. Dissociation from cationic dye binding and down-regulation by Na+ and K+.
Tedeschi A; Palella M; Milazzo N; Lorini M; Miadonna A
J Immunol; 1995 Sep; 155(5):2652-60. PubMed ID: 7544380
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of basophil histamine release by anti-inflammatory steroids. II. Studies on the mechanism of action.
Schleimer RP; MacGlashan DW; Gillespie E; Lichtenstein LM
J Immunol; 1982 Oct; 129(4):1632-6. PubMed ID: 6180017
[TBL] [Abstract][Full Text] [Related]
15. In vitro resistance to dexamethasone of basophils from patients receiving long-term steroid therapy.
Lampl KL; Lichtenstein LM; Schleimer RP
Am Rev Respir Dis; 1985 Nov; 132(5):1015-8. PubMed ID: 2415027
[TBL] [Abstract][Full Text] [Related]
16. Study of IgE-dependent basophil releasability in allergic patients.
Sanz ML; Latasa M; García BE; Gato JJ; Oehling A
J Investig Allergol Clin Immunol; 1991 Oct; 1(5):293-301. PubMed ID: 1727011
[TBL] [Abstract][Full Text] [Related]
17. Expression of actin and tubulins in purified human basophil leukocytes upon stimulation with IL-3.
Nielsen HV; Johnsen AH; Schiøtz PO
Int Arch Allergy Immunol; 2004 Apr; 133(4):340-7. PubMed ID: 15031607
[TBL] [Abstract][Full Text] [Related]
18. Human basophil releasability. VI. Changes in basophil releasability in patients with allergic rhinitis or bronchial asthma.
Casolaro V; Spadaro G; Marone G
Am Rev Respir Dis; 1990 Nov; 142(5):1108-11. PubMed ID: 1700653
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the inhibitory effect of cromoline and nedocromil Na on histamine release from airway metachromatic cells and from peripheral basophils.
Kivity S; On A; Agami O; Levo Y; Fireman E
Immunol Lett; 1996 Nov; 53(2-3):147-51. PubMed ID: 9024994
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo effect of salbutamol on histamine release from human basophils.
Chazan R; Walajtys-Rode E; Grubek-Jaworska H; Madalinska M; Droszcz W
Int J Clin Pharmacol Ther Toxicol; 1991 Jan; 29(1):9-13. PubMed ID: 1706328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
